Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia

Vaccine ◽  
2012 ◽  
Vol 30 (40) ◽  
pp. 5886-5892 ◽  
Author(s):  
Juan Alberto Benavides ◽  
Oscar Omar Ovalle ◽  
Galo R. Salvador ◽  
Sharon Gray ◽  
Daniel Isaacman ◽  
...  
Vaccine ◽  
2012 ◽  
Vol 30 (10) ◽  
pp. 1901-1909 ◽  
Author(s):  
Ana Lucia Andrade ◽  
Renato Oliveira ◽  
Maria A. Vieira ◽  
Ruth Minamisava ◽  
Vicente Pessoa ◽  
...  

2016 ◽  
Vol 3 ◽  
pp. 629-638 ◽  
Author(s):  
Jacek Wysocki ◽  
Wojciech Sluzewski ◽  
Elane Gutterman ◽  
Sylvie Jouve ◽  
Michele Moscariello ◽  
...  

2017 ◽  
Vol 145 (6) ◽  
pp. 1203-1209 ◽  
Author(s):  
A. RÖCKERT TJERNBERG ◽  
J. BONNEDAHL ◽  
M. INGHAMMAR ◽  
A. EGESTEN ◽  
G. KAHLMETER ◽  
...  

SUMMARYSevere infections are recognized complications of coeliac disease (CD). In the present study we aimed to examine whether individuals with CD are at increased risk of invasive pneumococcal disease (IPD). To do so, we performed a population-based cohort study including 29 012 individuals with biopsy-proven CD identified through biopsy reports from all pathology departments in Sweden. Each individual with CD was matched with up to five controls (n = 144 257). IPD events were identified through regional and national microbiological databases, including the National Surveillance System for Infectious Diseases. We used Cox regression analyses to estimate hazard ratios (HRs) for diagnosed IPD. A total of 207 individuals had a record of IPD whereas 45/29 012 had CD (0·15%) and 162/144 257 were controls (0·11%). This corresponded to a 46% increased risk for IPD [HR 1·46, 95% confidence interval (CI) 1·05–2·03]. The risk estimate was similar after adjustment for socioeconomic status, educational level and comorbidities, but then failed to attain statistical significance (adjusted HR 1·40, 95% CI 0·99–1·97). Nonetheless, our study shows a trend towards an increased risk for IPD in CD patients. The findings support results seen in earlier research and taking that into consideration individuals with CD may be considered for pneumococcal vaccination.


2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
T. J. Marrie ◽  
G. J. Tyrrell ◽  
Sumit R. Majumdar ◽  
Dean T. Eurich

Background.Large studies of invasive pneumococcal disease (IPD) are frequently lacking detailed clinical information.Methods.A population-based 15-year study of IPD in Northern Alberta.Results.2435 patients with a mean age of 54.2 years formed the study group. Males outnumbered females and Aboriginal and homeless persons were overrepresented. High rates of smoking, excessive alcohol use, and illicit drug use were seen. Almost all (87%) had a major comorbidity and 15% had functional limitations prior to admission. Bacteremia, pneumonia, and meningitis were the most common major manifestations of IPD. Almost half of the patients had alteration of mental status at the time of admission and 22% required mechanical ventilation. Myocardial infarction, pulmonary embolism, and new onset stroke occurred in 1.7, 1.3, and 1.1% of the patients, respectively; of those who had echocardiograms, 35% had impaired ventricular function. The overall in-hospital mortality was 15.6%.Conclusions.IPD remains a serious infection in adults. In addition to immunization, preventative measures need to consider the sociodemographic features more carefully. A standard set of data need to be collected so that comparisons can be made from study to study. Future investigations should target cardiac function and pulmonary embolism prevention in this population.


Sign in / Sign up

Export Citation Format

Share Document